PROPRIETARY INVESTMENTS

OUR FUNDS

A joint venture between Ziegler and Link-Age Linkage Logo

Fund description/investment policy

The increasing aging population of the United States presents an attractive investment opportunity, given the size, growth and complexity of needs of this population within a continually evolving healthcare system. While the current venture capital and start-up market generally has a broad focus across the landscape of acute healthcare providers, this fund takes a concentrated approach by investing in companies that serve the Longevity Economy. The fund sponsors, Ziegler and Link-Age, leverage their domain knowledge and relationships to find attractive investment opportunities through an investment management team with relevant experience in the space.

 

The objective of the Fund is to achieve long-term capital appreciation by making equity and equity-like (including convertible debt) investments in early to mid-stage, emerging-growth companies that operate in or develop businesses focused on the Longevity Economy.

 

Key investment themes will include, but are not limited to, the following:

  • Aging in place;
  • Coordination of care;
  • Chronic disease management;
  • Reduction of hospitalizations and readmissions;
  • Disease prevention and wellness strategies; and
  • Government funded programs / public health related matters.

 

Investor Access                    Investor Statements Portal

 

The fund also provides a unique platform for collaboration and innovation among the limited partners, who are primarily comprised of approximately 70 not-for-profit senior living providers from across the nation and select other healthcare focused organizations, and thus have a direct interest in the companies in which the fund will invest. Not only can the investor base act as a source of information on market needs and operator preferences to the fund managers, but it also represents a potential group of customers for some portfolio companies. The vintage year of the Ziegler Link-Age Longevity Fund is 2014. 

 

Portfolio Companies


Investment Managers

John Hopper, Chief Investment Officer
John Hopper currently serves as the Managing Director of Link•Age Ventures, a wholly owned subsidiary of Link•Age focused on making investments in companies providing products, services and technology to the aging marketplace. John was also the Founder and Partner of Silverstone Advisors – Blackbird Capital Group, LLC (“Silverstone”). Silverstone is a boutique investment banking firm providing merger and acquisition services, including valuation, due diligence, capital raising, buy side engagements and sell side engagements. Prior to the founding of Silverstone, he was the Chief Executive Officer of a regional network servicing company, and held numerous executive positions in the financial services industry with Fifth Third Bank, AmSouth Bank and Mellon Bank. John holds a J.D. degree from The Ohio State University College of Law and an M.B.A. from the University of Pittsburgh. Hopper received his B.A. from Mount Union College.

Neil Borg, Chief Strategic Officer
Neil Borg currently serves as the managing director and head of Ziegler’s Corporate Finance Healthcare efforts and is an advisor to the firm’s principal investing initiatives. Prior to joining Ziegler, Neil was in the Healthcare Services Investment Banking divisions of J.P. Morgan (previously Chase H&Q and Hambrecht & Quist) and Friedman, Billings, Ramsey. While at Hambrecht & Quist, he was associated with an affiliated venture capital fund, H&Q Serv*s Ventures, focused on early stage healthcare investments on behalf of Hambrecht & Quist and Johnson & Johnson. Over his career, Neil has advised on over 65 transactions, including strategic advisory assignments, public and private equity financings and equity investments principally for emerging growth companies in the healthcare services and healthcare information technology sectors. In addition, Neil currently sits on the Board of Directors of Auditz, and was most recently on the Board of Directors of Certify Data Systems prior to its sale to Humana in 2012.

Charles O’Meara, Chief Administrative Officer
Charles O’Meara became senior managing director - Private Equity for Ziegler in 2006. In this capacity, he is responsible for the oversight and development of the firm’s venture capital strategy, which focuses on the healthcare industry. Charles was instrumental in Ziegler’s launch of its venture capital initiative, with approximately $100 million of capital commitments in three venture funds. He serves on the boards of Ridgestone Financial Services, Masterpiece Living, and Orthosensor, Inc., a medical device company. From 1993 until 2006, Charles served as General Counsel of Ziegler.

Scott Collins, Managing Director
Scott Collins is the CEO of Link•Age and is responsible for its strategic direction and growth. Link•Age is comprised of three integrated entities: Link•Age Solutions – providing cost containment services to more than 600 senior living providers, Link•Age Ventures – investing in companies with products, services and technologies for the aging population and Link•Age Connect – delivering market research and insight for organizations seeking to better understand the older adult demographic. Prior to joining Link•Age, Scott was a vice president and senior account executive with GE Capital Commercial Asset Funding and held senior management positions in the commercial real estate as well as textile industries.

Ziegler Meditech Equity Partners

A joint venture between Ziegler and MediTech Advisors  

 

The medical device industry continues to experience growth and provides the basis for improved clinical outcomes for patients world-wide. The approaching wave of over-65 Baby Boomers, combined with developments in fields such as wireless communications, medical imaging, sensor technology, and molecular research are expected to drive continued market expansion. Ziegler Meditech Equity Partners, LP (ZMEP) is invested in the potential of this dynamic through equity investments in emerging medical device technologies. ZMEP invested globally, drawing on the years of investing experience of its management team, and is currently harvesting its outstanding investments. With more than 50 years of experience in medical device development and commercialization, the ZMEP management team worked with leading entrepreneurs in the medical device field in both the United States and Israel. The general partner of Ziegler Meditech Equity Partners is a joint venture between Ziegler and Meditech Advisors, an Israel based healthcare consultancy. The vintage year of the Ziegler Meditech Equity Partners is 2006. 

 

Portfolio Companies

               
       
   
   
   
   
   


Investment Managers

Charles O’Meara, Chief Administrative Officer
Charles O’Meara became senior managing director - Private Equity for Ziegler in 2006. In this capacity, he is responsible for the oversight and development of the firm’s venture capital strategy, which focuses on the healthcare industry. Charles was instrumental in Ziegler’s launch of its venture capital initiative, with approximately $100 million of capital commitments in three venture funds. He serves on the boards of Ridgestone Financial Services, Masterpiece Living, and Orthosensor, Inc., a medical device company. From 1993 until 2006, he served as General Counsel of Ziegler.

Dr. S. Morry Blumenfeld, Chief Investment Officer

Dr. Blumenfeld retired from GE Healthcare in 2002, having been with GE for over 34 years, and finished his career as a Managing Director of GE Medical Systems in Israel. Dr. Blumenfeld has considerable experience in developing and commercializing large scale diagnostic imaging systems, as well as new image guided equipment designed to provide non-invasive and minimally invasive procedures. Among other accomplishments, Dr. Blumenfeld was one of the managers responsible for developing GE’s computed tomography (“CT”) and magnetic resonance imaging (“MRI”) product lines, each of which now have annual sales over $1 billion. Dr. Blumenfeld serves on a number of academic boards as well as the board of some medical device companies.

Samual Cubac
Samual Cubac most recently worked as a vice president of GE Equity, where he managed the Tel Aviv, Israel office of GE Equity and assisted in managing GE’s limited partnership investment in ABS Giza GE Capital Fund II as well as Giza GE Venture Fund III. Both of these funds were global venture capital funds that invested in technology companies. Prior to GE, Samual was the senior vice president of AIG’s leasing & Equipment Financing Group, and prior to that was the CFO of AI Credit Corporation, AIG’s Finance subsidiary. In these positions, he managed over 100 professionals and a portfolio of $700 million of assets.

Eitan Machover
Eitan Machover was most recently a consultant with GE and has held various positions with GE, including sven years with GE healthcare as general manager of Integration and Business Development as well as a number of positions within the GE Commercial Services Division. He also served as the national executive for General Electric in Israel, where he was generally responsible for GE’s overall operations and growth in Israel. Eithan has held a number of international business development positions with a focus on third party service and technology driven acquisitions.

Donald Grande, Chief Administrative Officer
Donald Grande retired from Ziegler in 2014. Donald has over 50 years of experience advising clients in investment banking, corporate finance, tax matters and investments. He co-founded Grande, Schnoll & Associates in 1991, a consulting firm in which he focused on problem solving related to debt and equity transactions, and bank relations, which became GS2 and was ultimate merged into a subsidiary of Ziegler. Prior to founding Grande, Schnoll & Associates, he was a vice president involved in transactions and management of portfolio companies at Zilber, Ltd., a company with diversified real estate and equity interests, and was President of Sampson Investments, Inc., which had diversified interests in real estate, telecommunications and a variety of other industries. Donald is a CPA and has a JD in Law, and spent 15 years with Arthur Young and Company (now Ernst and Young), where he was a partner and director of the Tax Department.

Closed End Funds

Closed Funds

  • Ziegler Equity Funding Funds I-V: Seed capital funds for senior living developments
  • Ziegler Healthcare Real Estate Funds I-IV: Funds focused on investing in healthcare real estate, typically leased to physicians, hospitals, dialysis and imaging centers, healthcare delivery systems, and other healthcare providers.
  • Ziegler Healthcare Fund I: Small Business Investment Company licensed under the SBA, focused on providing financing to small to mid-size privately owned companies that provide long-term care services to seniors in the form of mezzanine debt and preferred equity.
  • Ziegler Healthcare Fund II: Leveraged senior mortgage fund focused on small to mid-size privately owned companies that provide long-term care services to seniors.
  • Ziegler Healthcare Fund III: Mezzanine debt and equity fund focused on small to mid-size privately owned companies that provide long-term care services to seniors.
  • Ziegler Healthvest Partners: Venture capital fund focused on investing in companies that provide services or information technology to healthcare providers, with an emphasis on acute care providers.